HMGCR and metabolic dysfunction-associated steatotic liver disease: Both the biologically active form of dephosphorylated HMGCR and the HMGCR transcription are increased in the liver tissues of nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) patients, suggesting severe cholesterol metabolism in patients with NAFLD [124].